India · Delayed Price · Currency is INR Accretion Pharmaceuticals Statistics
Total Valuation
NSE:ACCPL has a market cap or net worth of INR 2.25 billion. The enterprise value is 2.33 billion.
| Market Cap | 2.25B |
| Enterprise Value | 2.33B |
Important Dates
The next estimated earnings date is Friday, August 28, 2026.
| Earnings Date | Aug 28, 2026 |
| Ex-Dividend Date | n/a |
Share Statistics
NSE:ACCPL has 11.12 million shares outstanding. The number of shares has increased by 33.55% in one year.
| Current Share Class | 11.12M |
| Shares Outstanding | 11.12M |
| Shares Change (YoY) | +33.55% |
| Shares Change (QoQ) | +7.68% |
| Owned by Insiders (%) | 73.50% |
| Owned by Institutions (%) | n/a |
| Float | 2.95M |
Valuation Ratios
The trailing PE ratio is 22.40.
| PE Ratio | 22.40 |
| Forward PE | n/a |
| PS Ratio | 2.51 |
| PB Ratio | 4.11 |
| P/TBV Ratio | 4.11 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | 24.12 |
| EV / Sales | 2.60 |
| EV / EBITDA | 15.48 |
| EV / EBIT | 16.84 |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 2.90, with a Debt / Equity ratio of 0.23.
| Current Ratio | 2.90 |
| Quick Ratio | 1.41 |
| Debt / Equity | 0.23 |
| Debt / EBITDA | 0.82 |
| Debt / FCF | -0.53 |
| Interest Coverage | 18.72 |
Financial Efficiency
Return on equity (ROE) is 27.62% and return on invested capital (ROIC) is 16.24%.
| Return on Equity (ROE) | 27.62% |
| Return on Assets (ROA) | 14.85% |
| Return on Invested Capital (ROIC) | 16.24% |
| Return on Capital Employed (ROCE) | 24.80% |
| Weighted Average Cost of Capital (WACC) | n/a |
| Revenue Per Employee | 6.79M |
| Profits Per Employee | 732,386 |
| Employee Count | 132 |
| Asset Turnover | 1.54 |
| Inventory Turnover | 2.68 |
Taxes
In the past 12 months, NSE:ACCPL has paid 34.16 million in taxes.
| Income Tax | 34.16M |
| Effective Tax Rate | 26.11% |
Stock Price Statistics
The stock price has increased by +244.05% in the last 52 weeks.
| Beta (5Y) | n/a |
| 52-Week Price Change | +244.05% |
| 50-Day Moving Average | 167.05 |
| 200-Day Moving Average | 105.16 |
| Relative Strength Index (RSI) | 67.09 |
| Average Volume (20 Days) | 19,440 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, NSE:ACCPL had revenue of INR 896.27 million and earned 96.68 million in profits. Earnings per share was 9.03.
| Revenue | 896.27M |
| Gross Profit | 239.81M |
| Operating Income | 138.48M |
| Pretax Income | 130.83M |
| Net Income | 96.68M |
| EBITDA | 150.59M |
| EBIT | 138.48M |
| Earnings Per Share (EPS) | 9.03 |
Balance Sheet
The company has 40.21 million in cash and 123.21 million in debt, with a net cash position of -83.01 million or -7.47 per share.
| Cash & Cash Equivalents | 40.21M |
| Total Debt | 123.21M |
| Net Cash | -83.01M |
| Net Cash Per Share | -7.47 |
| Equity (Book Value) | 547.09M |
| Book Value Per Share | 49.22 |
| Working Capital | 395.58M |
Cash Flow
In the last 12 months, operating cash flow was -145.34 million and capital expenditures -85.34 million, giving a free cash flow of -230.68 million.
| Operating Cash Flow | -145.34M |
| Capital Expenditures | -85.34M |
| Depreciation & Amortization | 12.11M |
| Net Borrowing | -17.82M |
| Free Cash Flow | -230.68M |
| FCF Per Share | -20.75 |
Margins
Gross margin is 26.76%, with operating and profit margins of 15.45% and 10.79%.
| Gross Margin | 26.76% |
| Operating Margin | 15.45% |
| Pretax Margin | 14.60% |
| Profit Margin | 10.79% |
| EBITDA Margin | 16.80% |
| EBIT Margin | 15.45% |
| FCF Margin | n/a |
Dividends & Yields
NSE:ACCPL does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -33.55% |
| Shareholder Yield | -33.55% |
| Earnings Yield | 4.30% |
| FCF Yield | -10.26% |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | |
| Graham Upside |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
NSE:ACCPL has an Altman Z-Score of 4.78 and a Piotroski F-Score of 4.
| Altman Z-Score | 4.78 |
| Piotroski F-Score | 4 |